(Q43901439)

English

HPMA-hydrogels result in prolonged delivery of anticancer drugs and are a promising tool for the treatment of sensitive and multidrug resistant leukaemia

scientific article published in March 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

HPMA-hydrogels result in prolonged delivery of anticancer drugs and are a promising tool for the treatment of sensitive and multidrug resistant leukaemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

based on heuristic

inferred from title

multiple drug resistance

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

St'astný M

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Plocová D

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Etrych T

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Ulbrich K

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Ríhová B

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 March 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

602-608

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900421-X

7 January 2021

based on heuristic

inferred from DOI database lookup

HPMA-based biodegradable hydrogels containing different forms of doxorubicin. Antitumor effects and biocompatibility.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900421-X

7 January 2021

based on heuristic

inferred from DOI database lookup

P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900421-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of passive transbilayer drug movement in multidrug resistance and its modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900421-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Myeloid and lymphoid cell alterations in normal mice exposed to chemotherapy with doxorubicin and/or the multidrug-resistance reversing agent SDZ PSC 833.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900421-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900421-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Biodegradable polymeric nanoparticles as drug delivery devices

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900421-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein delivery from biodegradable microspheres.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900421-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Hydrogels in pharmaceutical formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900421-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody-directed affinity therapy applied to the immune system: in vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900421-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A possibility to overcome P-glycoprotein (PGP)-mediated multidrug resistance by antibody-targeted drugs conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer carrier

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900421-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(01)00421-X

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43901439&oldid=2104262794"